Luting Yu

440 total citations
26 papers, 315 citations indexed

About

Luting Yu is a scholar working on Surgery, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Luting Yu has authored 26 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Oncology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Luting Yu's work include Pancreatic function and diabetes (8 papers), Birth, Development, and Health (5 papers) and Diabetes and associated disorders (5 papers). Luting Yu is often cited by papers focused on Pancreatic function and diabetes (8 papers), Birth, Development, and Health (5 papers) and Diabetes and associated disorders (5 papers). Luting Yu collaborates with scholars based in China, Canada and United States. Luting Yu's co-authors include Chen Luo, Yuanzhen Zhang, Jin Zhou, Wen Huang, Hui Wang, Guohui Zhang, Lili Ren, Guoguang Chen, Wei Zhang and Jia Liu and has published in prestigious journals such as Biomaterials, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Luting Yu

21 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luting Yu China 13 90 88 58 53 48 26 315
Amira Osman Egypt 14 48 0.5× 132 1.5× 31 0.5× 57 1.1× 108 2.3× 41 558
Katharina Sommer Germany 12 103 1.1× 159 1.8× 23 0.4× 15 0.3× 72 1.5× 28 405
So Youn Kim South Korea 10 85 0.9× 114 1.3× 133 2.3× 16 0.3× 35 0.7× 19 542
Perihan Arslan Türkiye 8 73 0.8× 83 0.9× 36 0.6× 17 0.3× 54 1.1× 14 348
Mehdi Sahmani Iran 10 32 0.4× 179 2.0× 24 0.4× 38 0.7× 42 0.9× 36 468
Xuemei Zhang China 12 100 1.1× 160 1.8× 87 1.5× 24 0.5× 41 0.9× 25 580
Sweta B. Patel United States 9 64 0.7× 174 2.0× 31 0.5× 12 0.2× 123 2.6× 39 579
Elisavet Kouvidi Greece 8 35 0.4× 97 1.1× 29 0.5× 49 0.9× 24 0.5× 24 309
Seyed Morteza Seifati Iran 11 24 0.3× 159 1.8× 34 0.6× 34 0.6× 17 0.4× 39 403
Ying Peng China 12 27 0.3× 158 1.8× 62 1.1× 116 2.2× 28 0.6× 28 401

Countries citing papers authored by Luting Yu

Since Specialization
Citations

This map shows the geographic impact of Luting Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luting Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luting Yu more than expected).

Fields of papers citing papers by Luting Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luting Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luting Yu. The network helps show where Luting Yu may publish in the future.

Co-authorship network of co-authors of Luting Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Luting Yu. A scholar is included among the top collaborators of Luting Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luting Yu. Luting Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Qingyun, Shibo Jiang, Jia Liu, et al.. (2025). Regenerating Family Protein 3α‐Loaded Responsive Hydrogel Accelerates Infected Diabetic Wound Healing. Advanced Healthcare Materials. 14(13). e2500403–e2500403. 3 indexed citations
3.
Yu, Luting, Y. Lou, Yaning Li, et al.. (2025). A redox-responsive nanoparticle with RGD-targeted effect for photo-chemo therapy of triple-negative breast cancer. Materials Today Nano. 31. 100647–100647.
4.
Yu, Luting, Xiaonan Wang, Youjie Li, et al.. (2024). Reg2 treatment is protective but the induced Reg2 autoantibody is destructive to the islets in NOD mice. Biochemical Pharmacology. 227. 116444–116444. 1 indexed citations
5.
Mao, Li, et al.. (2024). Reg3A Overexpression Facilitates Hepatic Metastasis by Altering Cell Adhesion in LoVo Colon Cancer Cells. DNA and Cell Biology. 43(6). 298–310. 2 indexed citations
6.
Yu, Luting, Qingyun Wu, Shibo Jiang, et al.. (2024). Controversial Roles of Regenerating Family Proteins in Tissue Repair and Tumor Development. Biomedicines. 13(1). 24–24.
7.
Zhang, Wei, et al.. (2023). Zn-MOF hydrogel: regulation of ROS-mediated inflammatory microenvironment for treatment of atopic dermatitis. Journal of Nanobiotechnology. 21(1). 163–163. 43 indexed citations
9.
Yu, Luting, et al.. (2023). Tumor-suppressive effect of Reg3A in COAD is mediated by T cell activation in nude mice. Biomedicine & Pharmacotherapy. 169. 115922–115922. 6 indexed citations
10.
Yu, Luting, Jun‐Li Liu, Hao Sun, et al.. (2022). Recombinant Reg3α Prevents Islet β-Cell Apoptosis and Promotes β-Cell Regeneration. International Journal of Molecular Sciences. 23(18). 10584–10584. 11 indexed citations
11.
Han, Ran, Luting Yu, Ying Li, et al.. (2022). Inhibition of SerpinB9 to enhance granzyme B-based tumor therapy by using a modified biomimetic nanoplatform with a cascade strategy. Biomaterials. 288. 121723–121723. 28 indexed citations
12.
Du, Pei, Xiaonan Wang, Xueqing Zhang, et al.. (2020). Anti-tumor effect of single-chain antibody to Reg3a in colorectal cancer. Experimental Cell Research. 396(1). 112278–112278. 12 indexed citations
13.
Zhang, Guohui, Jin Zhou, Wen Huang, et al.. (2019). Prenatal ethanol exposure-induced a low level of foetal blood cholesterol and its mechanism of IGF1-related placental cholesterol transport dysfunction. Toxicology. 424. 152237–152237. 6 indexed citations
14.
Zhang, Guohui, Jin Zhou, Wen Huang, et al.. (2018). Placental mechanism of prenatal nicotine exposure-reduced blood cholesterol levels in female fetal rats. Toxicology Letters. 296. 31–38. 13 indexed citations
15.
Zhou, Jin, Luting Yu, Dan Xu, et al.. (2018). nAChRs-ERK1/2-Egr-1 signaling participates in the developmental toxicity of nicotine by epigenetically down-regulating placental 11β-HSD2. Toxicology and Applied Pharmacology. 344. 1–12. 19 indexed citations
16.
Luo, Chen, Luting Yu, Mengqi Yang, et al.. (2016). Recombinant Reg3β protein protects against streptozotocin-induced β-cell damage and diabetes. Scientific Reports. 6(1). 35640–35640. 13 indexed citations
17.
Yu, Luting, Mengqi Yang, Jun‐Li Liu, et al.. (2015). Recombinant Reg3α protein protects against experimental acute pancreatitis in mice. Molecular and Cellular Endocrinology. 422. 150–159. 16 indexed citations
18.
Luo, Ying, Luting Yu, Tingting Yu, et al.. (2015). The association of DNA methyltransferase 1 gene polymorphisms with susceptibility to childhood acute lymphoblastic leukemia. Biomedicine & Pharmacotherapy. 73. 35–39. 6 indexed citations
19.
Satoh, Toru, Norio Abiru, M Kobayashi, et al.. (2011). CHOP deletion does not impact the development of diabetes but suppresses the early production of insulin autoantibody in the NOD mouse. APOPTOSIS. 16(4). 438–448. 19 indexed citations
20.
Babaya, Naru, Maki Nakayama, Hiroaki Moriyama, et al.. (2006). A new model of insulin-deficient diabetes: male NOD mice with a single copy of Ins1 and no Ins2. Diabetologia. 49(6). 1222–1228. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026